These pathways play a significant role in the pathogenesis of SMA, as indicated by the discovery of SMA disease-modifying genes, such as PLS3 and NCALD, which operate independently of SMN expression. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.